Health Industry Visionary Award Winner
Office
Contact
E:
P:
F:
VCARD
PDF version

Dr. Xu is Scientific Director of Neuroscience Discovery Research at Amgen. With 30+ years of neuroscience research experience, Xu joined Amgen in 2016 as a key contributor in building the company’s neuroscience strategy. She is a co-inventor for the first FDA-approved treatment designed to prevent migraine, which affects 18% of women in the U.S. She has also aided in the discovery and development of other therapeutics, including for schizophrenia and sleep disorders. Her areas of focus include neurodegeneration, psychiatry disorders, migraine, and analgesia.

Bar Admissions
Education